Canopy Growth

CANOPY GROWTH KICKS OFF THE NEW YEAR WITH NEW PRODUCTS FROM TWEED, 7ACRES, AND SPECTRUM THERAPEUTICS

Retrieved on: 
Wednesday, January 24, 2024
Cream, Therapy, Canopy Growth, GG, Myrcene, Citrus, Oil, Cannabinoid, TSX, Terpene, Lemon meringue pie, CBN, CBG, Phenotype, THC, MCT

"For our medical cannabis consumers, we're proud to continue delivering the variety and convenience that the Spectrum Therapeutics store is synonymous for thanks to new pre-rolls from 7ACRES and the Spectrum Reserve."

Key Points: 
  • "For our medical cannabis consumers, we're proud to continue delivering the variety and convenience that the Spectrum Therapeutics store is synonymous for thanks to new pre-rolls from 7ACRES and the Spectrum Reserve."
  • For consumers not wanting to compromise quality for quantity, Tweed Lemon Meringue Pie is being served up fresh in a large format 28g package.
  • Tweed's Lemon Meringue Pie boasts lemon, citrus and nutty vanilla aromas, is hang-dried, and comes in with a 23-29% THC range.
  • Exclusive for medical cannabis customers, Spectrum Therapeutics is extending its Spectrum Reserve collection with Alien Breath and (GG#4 x Mendo Breath) pre-roll joints.

Hemp-CBD Market Demand Gaining Momentum While Projected to Reach $16 Billion By 2025

Retrieved on: 
Thursday, January 11, 2024
Beer, Skin care, Pacific Northwest, CGC, Sale, DSM-IV codes, TLRY, Lead, United States farm bill, Growth, Drink, Food, Sleep, Tilray, CPG, Cosmetics, Uncle, Snack, PALM, ASX, Brink's, Mental health, Acquisition, Cannabis, OTCQX, Tobacco, Marketing, Smoke, Patient, Canopy Growth, Health, Oil, Digital, OTCQB, News, Intellectual property, Drug

A report from The Brightfield Group said: “It is no surprise to see that CBD is expected to grow to $16 billion by 2025.

Key Points: 
  • A report from The Brightfield Group said: “It is no surprise to see that CBD is expected to grow to $16 billion by 2025.
  • Especially as we see people turning to various CBD products for stress management or to promote better sleep.
  • What is most notable is that this market has grown almost exclusively based on word-of-mouth.
  • Canada saw over $3 billion in CBD revenue in 2020 from various products ranging from prerolls, oils, edibles, brinks, and vapes.

Canopy Growth Announces US$30 Million Private Placement

Retrieved on: 
Tuesday, January 9, 2024
Canopy Growth, Unit, Series, Prospectus, Sale, Indian stock exchange, TSX, News, Security (finance)

SMITHS FALLS, ON, Jan. 9, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC), today announced that it has entered into subscription agreements (the "Subscription Agreements"), dated as of January 9, 2024, with certain institutional investors (the "Investors") in a private placement offering (the "Offering") of 6,993,007 units ("Units") at a price per Unit of US$4.29 for aggregate gross proceeds of approximately US$30,000,000.

Key Points: 
  • SMITHS FALLS, ON, Jan. 9, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC), today announced that it has entered into subscription agreements (the "Subscription Agreements"), dated as of January 9, 2024, with certain institutional investors (the "Investors") in a private placement offering (the "Offering") of 6,993,007 units ("Units") at a price per Unit of US$4.29 for aggregate gross proceeds of approximately US$30,000,000.
  • The purpose of the Offering is to provide the Company with additional liquidity of US$30MM to further strengthen Canopy Growth's financial position.
  • Each Warrant will entitle the holder to acquire one Common Share from the Company at a price equal to US$4.83.
  • The closing of the private placement pursuant to the Subscription Agreements is expected to occur on or about January 10, 2024, subject to customary closing conditions.

Indiva Provides Corporate Update Including Improved Fourth Quarter Revenue Guidance

Retrieved on: 
Thursday, January 4, 2024
Cannabis, Natural Resources, Other Retail, Retail, Tobacco, TSX Venture Exchange, Red One, Plan, Limited, Sale, RSU, Consultant, Indian stock exchange, THC, The Red One, Stock, Growth, Investment, Option, No Future, Automation, Exercise, Canopy Growth, Security (finance)

Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA), the leading Canadian producer of cannabis edibles, is pleased to provide a corporate update and recap of fiscal 2023, including improved quarterly guidance, as the Company now expects record net revenue in the fourth quarter of 2023.

Key Points: 
  • Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA), the leading Canadian producer of cannabis edibles, is pleased to provide a corporate update and recap of fiscal 2023, including improved quarterly guidance, as the Company now expects record net revenue in the fourth quarter of 2023.
  • "Driven by Indiva's best-in-class distribution and store penetration, which exceeds 3,000 stores nationwide, Indiva continues to hold leading market share in the edibles category.
  • Additionally, Indiva has already sold more than two million No Future gummies and over 100,000 No Future vapes since the initial brand launch in B.C.
  • Continued strength in the Pearls by Grön and No Future brands has resulted in fourth quarter 2023 net revenue results, which are set to exceed the initial expectations and guidance provided in our third quarter results press release, dated November 21, 2023.

Canopy Growth Announces Completed Sale of This Works

Retrieved on: 
Monday, December 18, 2023
Sale, Sleep, Works, CAD, Intellectual property, CGC, Canopy Growth, Growth, TSX, Bank

SMITHS FALLS, ON and LONDON, Dec. 18, 2023 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) today announced that the Company has completed the divestiture of its This Works skincare and wellness brand to Inspirit Capital, a London-based investment firm.

Key Points: 
  • SMITHS FALLS, ON and LONDON, Dec. 18, 2023 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) today announced that the Company has completed the divestiture of its This Works skincare and wellness brand to Inspirit Capital, a London-based investment firm.
  • In accordance with the completed sale agreement, This Works' leadership, staff, and intellectual property will transfer to Inspirit Capital.
  • "We are resolutely focused on achieving North American cannabis market leadership, and this completed sale represents a further step to enable this through the transformation of Canopy Growth into a simplified, asset-light, cannabis focused business," said David Klein, CEO, Canopy Growth.
  • "We're proud of the legacy that This Works has built as part of the Canopy Growth family.

Canopy Growth Announces Effective Date of Share Consolidation

Retrieved on: 
Wednesday, December 13, 2023
Odyssey, Indian stock exchange, Consolidated financial statement, Consolidation, Exercise, Toronto Stock Exchange, CUSIP, CGC, Canopy Growth, Effective date, Beneficial, TSX, Letter

SMITHS FALLS, ON, Dec. 13, 2023 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) announced today that the Company's board of directors has approved the consolidation (the "Consolidation") of the Company's issued and outstanding common shares (the "Common Shares") on the basis of one (1) post-Consolidation Common Share for every ten (10) pre-Consolidation Common Shares.

Key Points: 
  • SMITHS FALLS, ON, Dec. 13, 2023 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) announced today that the Company's board of directors has approved the consolidation (the "Consolidation") of the Company's issued and outstanding common shares (the "Common Shares") on the basis of one (1) post-Consolidation Common Share for every ten (10) pre-Consolidation Common Shares.
  • The Consolidation was approved by the Company's shareholders at the annual general and special meeting of shareholders held on September 25, 2023.
  • "By implementing this share consolidation, Canopy Growth expects to regain compliance with the Nasdaq's bid requirement and further support the marketability of the Company's shares," said Judy Hong, Chief Financial Officer, Canopy Growth.
  • Shareholders of record as of the Effective Date will receive a letter of transmittal from Odyssey Trust Company, the transfer agent for the Common Shares, providing instructions for the exchange of their Common Shares as soon as practicable following the Effective Date.

Martha Stewart CBD Debuts New Need-Based Gummies Targeting Sleep, Stress, and Discomfort

Retrieved on: 
Wednesday, November 29, 2023
Holiday, Sleep, International, Canopy Growth, Cannabis, Partnership, Gamer, Marquee Brands, Taste, Life, Interior design, Online shopping, Montmorency, CBD

Just in time for the holidays, Martha Stewart CBD has unveiled a new line of need-based CBD gummies, broadening the brand's evolving wellness assortment.

Key Points: 
  • Just in time for the holidays, Martha Stewart CBD has unveiled a new line of need-based CBD gummies, broadening the brand's evolving wellness assortment.
  • Martha Stewart CBD products provide consumers with convenient, plant-based solutions to help people feel their best all day, every day.
  • The new Martha Stewart CBD needs-based gummies deliver just that – accessible, reliable relief when and where you need it most."
  • Martha Stewart CBD is now available on an affiliate program.

Canopy Growth Announces that BioSteel Obtains Court Approval of Successful Bids in Sale and Investment Solicitation Process

Retrieved on: 
Friday, November 17, 2023
Sale, Record, CCAA, Canopy Growth, Intellectual property, CGC, TSX, BioSteel, Bankruptcy, Bank, Security (finance), Cryptocurrency, Lease

Elimination of funding obligation to BioSteel consistent with Canopy Growth's cannabis focus and transformation to a simplified, asset-light operating model.

Key Points: 
  • Elimination of funding obligation to BioSteel consistent with Canopy Growth's cannabis focus and transformation to a simplified, asset-light operating model.
  • On September 21, 2023, the CCAA Court granted an order (the "SISP Order") authorizing BioSteel Canada to conduct, under the oversight of KSV Restructuring Inc., in its capacity as court-appointed monitor of BioSteel Canada, a sale and investment solicitation process (the "SISP") in accordance with the terms and conditions relating thereto (the "SISP Procedures").
  • a)    a sale of substantially all of the assets of BioSteel Canada (the "BioSteel Canada Transaction") as contemplated by an asset purchase agreement dated November 9, 2023 (the "BioSteel Canada Asset Purchase Agreement"); and
    b)    a sale of all or substantially all of the assets (the "BioSteel Manufacturing Transaction" and together with the BioSteel Canada Transaction, the "Sale Transactions") of BioSteel Canada's U.S. affiliate, BioSteel Manufacturing as contemplated by an asset purchase agreement dated November 9, 2023 (the "BioSteel Manufacturing Purchase Agreement").
  • The closing of the BioSteel Canada Transaction is subject to customary closing conditions and an order of the US Bankruptcy Court recognizing the approval of the BioSteel Canada Transaction.

Constellation Brands Announces Expiration of Canopy Growth Warrants

Retrieved on: 
Friday, November 3, 2023
Constellation, CBG, Canopy Growth, SEDAR, Tranche, Warrant, NYSE, Constellation Brands, Indian stock exchange, Exercise, Security (finance), Canopy

VICTOR, N.Y., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, announced today the expiration of all its warrants (“Warrants”) to purchase common shares (“Common Shares”) of Canopy Growth Corporation (“Canopy”).

Key Points: 
  • VICTOR, N.Y., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, announced today the expiration of all its warrants (“Warrants”) to purchase common shares (“Common Shares”) of Canopy Growth Corporation (“Canopy”).
  • All 88,472,861 Tranche A warrants held by Constellation’s wholly-owned subsidiary, CBG Holdings LLC (“CBG”), expired as of November 1, 2023.
  • Since the vesting of the remaining aggregate of 51,272,592 Tranche B and Tranche C warrants was conditioned on the exercise, in full, of the Tranche A warrants, the remaining Warrants are not, and will not become, exercisable by CBG.
  • As a result, Constellation is no longer deemed to beneficially own any of the 139,745,453 Common Shares underlying the Warrants.

Canopy Growth to Report Second Quarter Fiscal 2024 Financial Results on November 9, 2023

Retrieved on: 
Thursday, October 26, 2023
CFO, Canopy Growth, Webcast, TSX, Cryptocurrency

SMITHS FALLS, ON, Oct. 26, 2023 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) will release its financial results for the second quarter fiscal year 2024 ended September 30, 2023 after markets close on November 9, 2023.

Key Points: 
  • SMITHS FALLS, ON, Oct. 26, 2023 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) will release its financial results for the second quarter fiscal year 2024 ended September 30, 2023 after markets close on November 9, 2023.
  • Following the release of its second quarter fiscal year 2024 financial results, Canopy Growth will host an audio webcast with David Klein, CEO and Judy Hong, CFO on November 9, at 5:30 PM Eastern Time.
  • A live audio webcast will be available at: https://app.webinar.net/8jnJ0EJDRBz
    A replay will be accessible by webcast until 11:59 PM ET on February 7, 2024 at: https://app.webinar.net/8jnJ0EJDRBz